These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


248 related items for PubMed ID: 16625289

  • 21. Holmium laser ablation of the prostate versus photoselective vaporization of prostate 60 cc or less: short-term results of a prospective randomized trial.
    Elzayat EA, Al-Mandil MS, Khalaf I, Elhilali MM.
    J Urol; 2009 Jul; 182(1):133-8. PubMed ID: 19447438
    [Abstract] [Full Text] [Related]

  • 22. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.
    Bachmann A, Schürch L, Ruszat R, Wyler SF, Seifert HH, Müller A, Lehmann K, Sulser T.
    Eur Urol; 2005 Dec; 48(6):965-71; discussion 972. PubMed ID: 16126327
    [Abstract] [Full Text] [Related]

  • 23. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.
    Capitán C, Blázquez C, Martin MD, Hernández V, de la Peña E, Llorente C.
    Eur Urol; 2011 Oct; 60(4):734-9. PubMed ID: 21658839
    [Abstract] [Full Text] [Related]

  • 24. Predictability of irritative voiding symptoms following photoselective laser vaporization of the prostate.
    Matoka DJ, Averch TD.
    Can J Urol; 2007 Oct; 14(5):3710-4. PubMed ID: 17949529
    [Abstract] [Full Text] [Related]

  • 25. Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL.
    Pfitzenmaier J, Gilfrich C, Pritsch M, Herrmann D, Buse S, Haferkamp A, Djakovic N, Pahernik S, Hohenfellner M.
    BJU Int; 2008 Aug; 102(3):322-7. PubMed ID: 18422772
    [Abstract] [Full Text] [Related]

  • 26. [Photoselective vaporization of the prostate (PVP) using 80 watt high power potassium-titanyl-phosphate (KTP) laser for benign prostatic hyperplasia: the first fifty-seven patients in Japan].
    Kuromatsu I, Imamura T, Sugimura Y.
    Nihon Hinyokika Gakkai Zasshi; 2006 Nov; 97(7):815-22. PubMed ID: 17154023
    [Abstract] [Full Text] [Related]

  • 27. [Greenlight photoselective vaporization prostatectomy versus thulium laser vaporesection of the prostate for aged high-risk BPH patients with the prostate heavier than 80 g].
    Liu CL, Xue DW, Liu YL, Wang P.
    Zhonghua Nan Ke Xue; 2011 May; 17(5):431-4. PubMed ID: 21837954
    [Abstract] [Full Text] [Related]

  • 28. Technique and short-term outcome of green light laser (KTP, 80W) vaporisation of the prostate.
    Heinrich E, Schiefelbein F, Schoen G.
    Eur Urol; 2007 Dec; 52(6):1632-7. PubMed ID: 17689002
    [Abstract] [Full Text] [Related]

  • 29. Outcomes of 80 W KTP laser vaporization of the large prostate.
    Tugcu V, Tasci AI, Sahin S, Ordekci Y, Karakas OF, Zorluoglu F.
    Urol Int; 2007 Dec; 79(4):316-20. PubMed ID: 18025849
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effects of photoselective vaporization of the prostate on urodynamics in patients with benign prostatic hyperplasia.
    Seki N, Nomura H, Yamaguchi A, Naito S.
    J Urol; 2008 Sep; 180(3):1024-8; discussion 1028-9. PubMed ID: 18639299
    [Abstract] [Full Text] [Related]

  • 33. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Hamann MF, Naumann CM, Seif C, van der Horst C, Jünemann KP, Braun PM.
    Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565
    [Abstract] [Full Text] [Related]

  • 34. Decreased efficiency of potassium-titanyl-phosphate laser photoselective vaporization prostatectomy with long-term 5 alpha-reductase inhibition therapy: is it true?
    Araki M, Lam PN, Culkin DJ, Wong C.
    Urology; 2007 Nov; 70(5):927-30. PubMed ID: 18068449
    [Abstract] [Full Text] [Related]

  • 35. Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia.
    Chung DE, Wysock JS, Lee RK, Melamed SR, Kaplan SA, Te AE.
    J Urol; 2011 Sep; 186(3):977-81. PubMed ID: 21791350
    [Abstract] [Full Text] [Related]

  • 36. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation.
    Ruszat R, Wyler S, Forster T, Reich O, Stief CG, Gasser TC, Sulser T, Bachmann A.
    Eur Urol; 2007 Apr; 51(4):1031-8; discussion 1038-41. PubMed ID: 16945475
    [Abstract] [Full Text] [Related]

  • 37. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial.
    Horasanli K, Silay MS, Altay B, Tanriverdi O, Sarica K, Miroglu C.
    Urology; 2008 Feb; 71(2):247-51. PubMed ID: 18308094
    [Abstract] [Full Text] [Related]

  • 38. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a prospective randomized trial.
    Xue B, Zang Y, Zhang Y, Yang D, Gao J, Sun C, Cui Y, Zhu J, Liu X, Shan Y.
    J Xray Sci Technol; 2013 Feb; 21(1):125-32. PubMed ID: 23507858
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.